SMC phenotypic switching is a key phenomenon underlying several vessel-narrowing diseases, such as atherosclerosis, and our study showed that ANGPTL4 could be a potential regulator of SMC differentiation by blocking the transition to macrophage-like cell types by downregulating KLF4. Here, ANGPTL4 is linked to atherosclerosis.